Morningstar - Uni-President China Holdings Ltd. (58U) Uni-Presidentâ€™s 2H 2018 Results in Line; Shares Overvalued to Our HKD 5.80 Fair Value Estimate

Report

Morningstar

Allen Cheng

EUR 100.00 For Business Accounts Only

Uni-Presidentâ€™s 2H 2018 Results in Line; Shares Overvalued to Our HKD 5.80 Fair Value Estimate

No-moat Uni-President China Holdings reported 2018 full-year results largely in line with our forecasts. Our long-term view for the company is unchanged, as we believe it will retain its number two position in terms of market share in the instant noodles and tea drinks markets. We retain our no moat and stable trend ratings and maintain our fair value estimate at HKD 5.80 per share. Given its demanding valuation, we view the shares as overvalued at current levels.
Revenue and operating profit in...

25/03/2019 13 EN

Underlying

Uni-President China Holdings Ltd.

Uni-President China Holdings is an investment holding company based in the People's Republic of China. Co. is principally engaged in the manufacturing and sales of beverages and instant noodles. Through its subsidiaries, Co. is also engaged in activities such as: human resource management; management consulting; provision of catering services; wholesale of forage and fertilizer; wholesale and retail of pre-packaged food and dairy products; as well as leasing business. Co. operations are organized along three reportable business segments: Beverages, Instant Noodles, and Others.

See profile

KYG9222R1065 Cayman Islands

Provider

Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

See profile

Analysts

Allen Cheng

Other Reports on these Companies

SmartInsider

Uni-President China Holdings Ltd: 1 director

A director at Uni-President China Holdings Ltd bought 100,000 shares at 5.650HKD and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. ...

Free Trial

March 21, 2024 March 21, 2024 1 EN

TheScreener

With a more favourable environment, UNI-PRESIDENT CHINA HDG. improves to Positive

UNI-PRESIDENT CHINA HDG. (HK), a company active in the Soft Drinks industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 3 out of 4 stars, as well as its unchanged, defensive market behaviour. The title leverages a more favourable environment and raises its general evaluation to Positive. As of the analysis date February 15, 2022, the closing price was HKD 8.32 and its potential was estimated at HKD 8.97.

Free Trial

February 16, 2022 February 16, 2022 1 EN

Morningstar

Morningstar | Uni-Presidentâ€™s 48% Profit Growth in 1Q Beat; Shares Remain Overvalued to Our HKD 5.80 FVE

No-moat Uni-President China Holdings reported unaudited first-quarter profits of CNY 380.5 million, up 48% year on year, that exceeded our expectation. We think the strong profit stemmed from mix and gross margin expansion, while the revenue growth was at a mid-single-digits rate. Premium products continued to outperform, with Soup Daren for instant noodles and milk tea for the beverage segment growing at double digits. Although the upbeat first-quarter profit marked a good start for the year, it is a typical slow season for beverages business, which accounts for 70% of its total profits. We a...

EUR 850.00

May 8, 2019 May 8, 2019 3 EN

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Contract manufacturer Lonza reported solid half-year results, with over CHF 2.9 billion in total sales year to date, up about 6.4% from last year and boosted by foreign exchange tailwinds. Core EBITDA margin expanded 30 basis points from last year to about 27.8%, helped slightly by new accounting standards. Management indicated that it continues to expect mid- to high-single-digit sales growth in 2019. We are maintaining our fair value estimate of CHF 210 per share and our no-moat rating. The ph...

EUR 100.00

July 25, 2019 July 25, 2019 13 EN

Damien Conover

Damien Conover

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

We don't expect any major changes to our AstraZeneca fair value estimate following second-quarter results that largely fell in line with our expectations and slightly ahead of consensus expectations. Overall, the company is posting leading Big Pharma sales growth with total sales up 18% operationally year over year, led by impressive cancer drug sales growth of 57%. Astra's ability to continue to bring next generation drugs to the market that address unmet medical need (especially in oncology) s...

EUR 100.00

July 25, 2019 July 25, 2019 14 EN

Damien Conover

Damien Conover

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

EUR 100.00

July 25, 2019 July 25, 2019 14 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Uni-Presidentâ€™s 2H 2018 Results in Line; Shares Overvalued to Our HKD 5.80 Fair Value Estimate

Uni-President China Holdings Ltd: 1 director

With a more favourable environment, UNI-PRESIDENT CHINA HDG. improves to Positive

Morningstar | Uni-Presidentâ€™s 48% Profit Growth in 1Q Beat; Shares Remain Overvalued to Our HKD 5.80 FVE

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe